- Previous Close
5.3000 - Open
5.1000 - Bid 4.3400 x 900
- Ask 4.7000 x 900
- Day's Range
4.6200 - 5.1000 - 52 Week Range
3.8000 - 26.7000 - Volume
5,254 - Avg. Volume
9,242 - Market Cap (intraday)
20.059M - Beta (5Y Monthly) -0.27
- PE Ratio (TTM)
-- - EPS (TTM)
-11.8200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Dec 23, 2015
- 1y Target Est
--
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
www.concordmedical.com727
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: CCM
View MorePerformance Overview: CCM
Trailing total returns as of 1/12/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CCM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CCM
View MoreValuation Measures
Market Cap
20.06M
Enterprise Value
461.58M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.31
Price/Book (mrq)
--
Enterprise Value/Revenue
7.17
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-80.33%
Return on Assets (ttm)
-4.40%
Return on Equity (ttm)
-32.40%
Revenue (ttm)
471.7M
Net Income Avi to Common (ttm)
-378.93M
Diluted EPS (ttm)
-11.8200
Balance Sheet and Cash Flow
Total Cash (mrq)
326.9M
Total Debt/Equity (mrq)
185.55%
Levered Free Cash Flow (ttm)
--